Product Code: TMRGL73510
TMR's report on the global in-vitro toxicology testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global in-vitro toxicology testing market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in-vitro toxicology testing market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the in-vitro toxicology testing market.
The report delves into the competitive landscape of the global in-vitro toxicology testing market. Key players operating in the global in-vitro toxicology testing market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global in-vitro toxicology testing market profiled in this report.
Table of Contents
1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Summary of Statistics
- 1.3. Key Market Characteristics & Attributes
- 1.4. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage
- 2.2. Market Definition
3. Market Risks and Trends Assessment
- 3.1. Risk Assessment
- 3.1.1. COVID-19 Crisis and Impact on In-vitro Toxicology Testing Demand
- 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
- 3.1.3. Impact on Market Value (US$ Mn)
- 3.1.4. Assessment by Key Countries
- 3.1.5. Assessment by Key Market Segments
- 3.1.6. Action Points and Recommendation for Suppliers
- 3.2. Key Trends Impacting the Market
- 3.3. Formulation and Product Development Trends
4. Market Background
- 4.1. In-vitro Toxicology Testing Market, by Key Countries
- 4.2. In-vitro Toxicology Testing Market Opportunity Assessment (US$ Mn)
- 4.2.1. Total Available Market
- 4.2.2. Serviceable Addressable Market
- 4.2.3. Serviceable Obtainable Market
- 4.3. Market Scenario Forecast
- 4.3.1. Demand in optimistic Scenario
- 4.3.2. Demand in Likely Scenario
- 4.3.3. Demand in Conservative Scenario
- 4.4. Investment Feasibility Analysis
- 4.4.1. Investment in Established Markets
- 4.4.1.1. In Short Term
- 4.4.1.2. In Long Term
- 4.4.2. Investment in Emerging Markets
- 4.4.2.1. In Short Term
- 4.4.2.2. In Long Term
- 4.5. Forecast Factors - Relevance & Impact
- 4.5.1. Top Companies Historical Growth
- 4.5.2. Growth in Automation, By Country
- 4.5.3. In-vitro Toxicology Testing Adoption Rate, By Country
- 4.6. Market Dynamics
- 4.6.1. Market Driving Factors and Impact Assessment
- 4.6.2. Prominent Market Challenges and Impact Assessment
- 4.6.3. In-vitro Toxicology Testing Market Opportunities
- 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
- 5.1. Manufacturers' Focus on Low Penetration High Growth Markets
- 5.2. Banking on with Segments High Incremental Opportunity
- 5.3. Peer Benchmarking
6. Global In-vitro Toxicology Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032
- 6.1. Historical Market Analysis, 2017-2021
- 6.2. Current and Future Market Projections, 2022-2032
- 6.3. Y-o-Y Growth Trend Analysis
7. Global In-vitro Toxicology Testing Market Value Analysis 2017-2021 and Forecast, 2022-2032
- 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
- 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
8. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Method
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Mn) Analysis By Method, 2017-2021
- 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Method, 2022-2032
- 8.3.1. Cellular Assay
- 8.3.1.1. Live Cells
- 8.3.1.2. Fixed Cells
- 8.3.2. Biochemical Assay
- 8.3.3. In-Silico
- 8.3.4. Ex-vivo
- 8.4. Market Attractiveness Analysis By Method
9. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End-use
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Mn) Analysis By End-use, 2017-2021
- 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-use, 2022-2032
- 9.3.1. Pharmaceutical Industry
- 9.3.2. Cosmetics & Household Products
- 9.3.3. Academic Institutes and Research Laboratories
- 9.3.4. Diagnostics
- 9.3.5. Chemical Industry
- 9.3.6. Food Industry
- 9.4. Market Attractiveness Analysis By End-use
10. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Technology
- 10.1. Introduction / Key Findings
- 10.2. Historical Market Size (US$ Mn) Analysis By Technology, 2017-2021
- 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022-2032
- 10.3.1. Cell Culture Technology
- 10.3.2. High Throughput Technology
- 10.3.3. Molecular Imaging
- 10.3.4. OMICS Technology
- 10.4. Market Attractiveness Analysis By Technology
11. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Application
- 11.1. Introduction / Key Findings
- 11.2. Historical Market Size (US$ Mn) Analysis By Application, 2017-2021
- 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032
- 11.3.1. Systemic Toxicology
- 11.3.2. Dermal Toxicity
- 11.3.3. Endocrine Disruption
- 11.3.4. Occular Toxicity
- 11.3.5. Other Applications
- 11.4. Market Attractiveness Analysis By Application
12. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region
- 12.1. Introduction
- 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021
- 12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
- 12.3.1. North America
- 12.3.2. Latin America
- 12.3.3. Europe
- 12.3.4. Asia Pacific
- 12.3.5. Middle East and Africa (MEA)
- 12.4. Market Attractiveness Analysis By Region
13. North America In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032
- 13.1. Introduction
- 13.2. Pricing Analysis
- 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 13.4.1. By Country
- 13.4.1.1. U.S.
- 13.4.1.2. Canada
- 13.4.1.3. Rest of North America
- 13.4.2. By Method
- 13.4.3. By End-use
- 13.4.4. By Application
- 13.4.5. By Technology
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Country
- 13.5.2. By Method
- 13.5.3. By End-use
- 13.5.4. By Application
- 13.5.5. By Technology
14. Latin America In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032
- 14.1. Introduction
- 14.2. Pricing Analysis
- 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 14.4.1. By Country
- 14.4.1.1. Brazil
- 14.4.1.2. Mexico
- 14.4.1.3. Rest of Latin America
- 14.4.2. By Method
- 14.4.3. By End-use
- 14.4.4. By Application
- 14.4.5. By Technology
- 14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Method
- 14.5.3. By End-use
- 14.5.4. By Application
- 14.5.5. By Technology
15. Europe In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032
- 15.1. Introduction
- 15.2. Pricing Analysis
- 15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 15.4.1. By Country
- 15.4.1.1. Germany
- 15.4.1.2. France
- 15.4.1.3. U.K.
- 15.4.1.4. Italy
- 15.4.1.5. Benelux
- 15.4.1.6. Nordic Countries
- 15.4.1.7. Rest of Europe
- 15.4.2. By Method
- 15.4.3. By End-use
- 15.4.4. By Application
- 15.4.5. By Technology
- 15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Method
- 15.5.3. By End-use
- 15.5.4. By Application
- 15.5.5. By Technology
16. Asia Pacific In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032
- 16.1. Introduction
- 16.2. Pricing Analysis
- 16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 16.4.1. By Country
- 16.4.1.1. China
- 16.4.1.2. Japan
- 16.4.1.3. South Korea
- 16.4.1.4. Rest of Asia Pacific
- 16.4.2. By Method
- 16.4.3. By End-use
- 16.4.4. By Application
- 16.4.5. By Technology
- 16.5. Market Attractiveness Analysis
- 16.5.1. By Country
- 16.5.2. By Method
- 16.5.3. By End-use
- 16.5.4. By Application
- 16.5.5. By Technology
17. Middle East and Africa In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032
- 17.1. Introduction
- 17.2. Pricing Analysis
- 17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 17.4.1. By Country
- 17.4.1.1. GCC Countries
- 17.4.1.2. South Africa
- 17.4.1.3. Turkey
- 17.4.1.4. Rest of Middle East and Africa
- 17.4.2. By Method
- 17.4.3. By End-use
- 17.4.4. By Application
- 17.4.5. By Technology
- 17.5. Market Attractiveness Analysis
- 17.5.1. By Country
- 17.5.2. By Method
- 17.5.3. By End-use
- 17.5.4. By Application
- 17.5.5. By Technology
18. Key Countries In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032
- 18.1. Introduction
- 18.1.1. Market Value Proportion Analysis, By Key Countries
- 18.1.2. Global Vs. Country Growth Comparison
- 18.2. US In-vitro Toxicology Testing Market Analysis
- 18.2.1. Value Proportion Analysis by Market Taxonomy
- 18.2.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.2.2.1. By Method
- 18.2.2.2. By End-use
- 18.2.2.3. By Application
- 18.2.2.4. By Technology
- 18.3. Canada In-vitro Toxicology Testing Market Analysis
- 18.3.1. Value Proportion Analysis by Market Taxonomy
- 18.3.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.3.2.1. By Method
- 18.3.2.2. By End-use
- 18.3.2.3. By Application
- 18.3.2.4. By Technology
- 18.4. Mexico In-vitro Toxicology Testing Market Analysis
- 18.4.1. Value Proportion Analysis by Market Taxonomy
- 18.4.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.4.2.1. By Method
- 18.4.2.2. By End-use
- 18.4.2.3. By Application
- 18.4.2.4. By Technology
- 18.5. Brazil In-vitro Toxicology Testing Market Analysis
- 18.5.1. Value Proportion Analysis by Market Taxonomy
- 18.5.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.5.2.1. By Method
- 18.5.2.2. By End-use
- 18.5.2.3. By Application
- 18.5.2.4. By Technology
- 18.6. Germany In-vitro Toxicology Testing Market Analysis
- 18.6.1. Value Proportion Analysis by Market Taxonomy
- 18.6.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.6.2.1. By Method
- 18.6.2.2. By End-use
- 18.6.2.3. By Application
- 18.6.2.4. By Technology
- 18.7. France In-vitro Toxicology Testing Market Analysis
- 18.7.1. Value Proportion Analysis by Market Taxonomy
- 18.7.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.7.2.1. By Method
- 18.7.2.2. By End-use
- 18.7.2.3. By Application
- 18.7.2.4. By Technology
- 18.8. Italy In-vitro Toxicology Testing Market Analysis
- 18.8.1. Value Proportion Analysis by Market Taxonomy
- 18.8.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.8.2.1. By Method
- 18.8.2.2. By End-use
- 18.8.2.3. By Application
- 18.8.2.4. By Technology
- 18.9. BENELUX In-vitro Toxicology Testing Market Analysis
- 18.9.1. Value Proportion Analysis by Market Taxonomy
- 18.9.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.9.2.1. By Method
- 18.9.2.2. By End-use
- 18.9.2.3. By Application
- 18.9.2.4. By Technology
- 18.10. UK In-vitro Toxicology Testing Market Analysis
- 18.10.1. Value Proportion Analysis by Market Taxonomy
- 18.10.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.10.2.1. By Method
- 18.10.2.2. By End-use
- 18.10.2.3. By Application
- 18.10.2.4. By Technology
- 18.11. Nordic Countries In-vitro Toxicology Testing Market Analysis
- 18.11.1. Value Proportion Analysis by Market Taxonomy
- 18.11.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.11.2.1. By Method
- 18.11.2.2. By End-use
- 18.11.2.3. By Application
- 18.11.2.4. By Technology
- 18.12. China In-vitro Toxicology Testing Market Analysis
- 18.12.1. Value Proportion Analysis by Market Taxonomy
- 18.12.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.12.2.1. By Method
- 18.12.2.2. By End-use
- 18.12.2.3. By Application
- 18.12.2.4. By Technology
- 18.13. Japan In-vitro Toxicology Testing Market Analysis
- 18.13.1. Value Proportion Analysis by Market Taxonomy
- 18.13.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.13.2.1. By Method
- 18.13.2.2. By End-use
- 18.13.2.3. By Application
- 18.13.2.4. By Technology
- 18.14. South Korea In-vitro Toxicology Testing Market Analysis
- 18.14.1. Value Proportion Analysis by Market Taxonomy
- 18.14.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.14.2.1. By Method
- 18.14.2.2. By End-use
- 18.14.2.3. By Application
- 18.14.2.4. By Technology
- 18.15. GCC Countries In-vitro Toxicology Testing Market Analysis
- 18.15.1. Value Proportion Analysis by Market Taxonomy
- 18.15.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.15.2.1. By Method
- 18.15.2.2. By End-use
- 18.15.2.3. By Application
- 18.15.2.4. By Technology
- 18.16. South Africa In-vitro Toxicology Testing Market Analysis
- 18.16.1. Value Proportion Analysis by Market Taxonomy
- 18.16.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.16.2.1. By Method
- 18.16.2.2. By End-use
- 18.16.2.3. By Application
- 18.16.2.4. By Technology
- 18.17. Turkey In-vitro Toxicology Testing Market Analysis
- 18.17.1. Value Proportion Analysis by Market Taxonomy
- 18.17.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
- 18.17.2.1. By Method
- 18.17.2.2. By End-use
- 18.17.2.3. By Application
- 18.17.2.4. By Technology
- 18.17.3. Competition Landscape and Player Concentration in the Country
19. Market Structure Analysis
- 19.1. Market Analysis by Tier of Companies
- 19.2. Market Concentration
- 19.3. Market Share Analysis of Top Players
- 19.4. Market Presence Analysis
- 19.4.1. By Regional footprint of Players
- 19.4.2. Product footprint by Players
20. Competition Analysis
- 20.1. Competition Dashboard
- 20.2. Competition Benchmarking
- 20.3. Competition Deep Dive
- 20.3.1. MERCK KGAA
- 20.3.1.1. Overview
- 20.3.1.2. Product Portfolio
- 20.3.1.3. Sales Footprint
- 20.3.1.4. Strategy Overview
- 20.3.2. CHARLES RIVER
- 20.3.2.1. Overview
- 20.3.2.2. Product Portfolio
- 20.3.2.3. Sales Footprint
- 20.3.2.4. Strategy Overview
- 20.3.3. BIO-RAD LABORATORIES, INC.
- 20.3.3.1. Overview
- 20.3.3.2. Product Portfolio
- 20.3.3.3. Sales Footprint
- 20.3.3.4. Strategy Overview
- 20.3.4. ABBOTT
- 20.3.4.1. Overview
- 20.3.4.2. Product Portfolio
- 20.3.4.3. Sales Footprint
- 20.3.4.4. Strategy Overview
- 20.3.5. THERMO FISHER SCIENTIFIC INC.
- 20.3.5.1. Overview
- 20.3.5.2. Product Portfolio
- 20.3.5.3. Sales Footprint
- 20.3.5.4. Strategy Overview
- 20.3.6. CATALENT, INC.
- 20.3.6.1. Overview
- 20.3.6.2. Product Portfolio
- 20.3.6.3. Sales Footprint
- 20.3.6.4. Strategy Overview
- 20.3.7. GE HEALTHCARE
- 20.3.7.1. Overview
- 20.3.7.2. Product Portfolio
- 20.3.7.3. Sales Footprint
- 20.3.7.4. Strategy Overview
- 20.3.8. QUEST DIAGNOSTICS INCORPORATED
- 20.3.8.1. Overview
- 20.3.8.2. Product Portfolio
- 20.3.8.3. Sales Footprint
- 20.3.8.4. Strategy Overview
- 20.3.9. EUROFINS SCIENTIFIC
- 20.3.9.1. Overview
- 20.3.9.2. Product Portfolio
- 20.3.9.3. Sales Footprint
- 20.3.9.4. Strategy Overview
- 20.3.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
- 20.3.10.1. Overview
- 20.3.10.2. Product Portfolio
- 20.3.10.3. Sales Footprint
- 20.3.10.4. Strategy Overview
- 20.3.11. EVOTEC
- 20.3.11.1. Overview
- 20.3.11.2. Product Portfolio
- 20.3.11.3. Sales Footprint
- 20.3.11.4. Strategy Overview
- 20.3.12. CREATIVE BIOARRAY
- 20.3.12.1. Overview
- 20.3.12.2. Product Portfolio
- 20.3.12.3. Sales Footprint
- 20.3.12.4. Strategy Overview
- 20.3.13. GENTRONIX
- 20.3.13.1. Overview
- 20.3.13.2. Product Portfolio
- 20.3.13.3. Sales Footprint
- 20.3.13.4. Strategy Overview
- 20.3.14. BIOIVT
- 20.3.14.1. Overview
- 20.3.14.2. Product Portfolio
- 20.3.14.3. Sales Footprint
- 20.3.14.4. Strategy Overview
- 20.3.15. SGS SA
- 20.3.15.1. Overview
- 20.3.15.2. Product Portfolio
- 20.3.15.3. Sales Footprint
- 20.3.15.4. Strategy Overview
- 20.3.16. AGILENT TECHNOLOGIES
- 20.3.16.1. Overview
- 20.3.16.2. Product Portfolio
- 20.3.16.3. Sales Footprint
- 20.3.16.4. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology